These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29368137)

  • 1. The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.
    Zelniker TA; Huscher D; Vonk-Noordegraaf A; Ewert R; Lange TJ; Klose H; Dumitrescu D; Halank M; Held M; Gall H; Pittrow D; Hoeper MM; Frankenstein L
    Clin Res Cardiol; 2018 Jun; 107(6):460-470. PubMed ID: 29368137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creation of a model comparing 6-minute walk test to metabolic equivalent in evaluating treatment effects in pulmonary arterial hypertension.
    Gomberg-Maitland M; Huo D; Benza RL; McLaughlin VV; Tapson VF; Barst RJ
    J Heart Lung Transplant; 2007 Jul; 26(7):732-8. PubMed ID: 17613405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance.
    Farber HW; Miller DP; McGoon MD; Frost AE; Benton WW; Benza RL
    J Heart Lung Transplant; 2015 Mar; 34(3):362-8. PubMed ID: 25312386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of baseline predictors of prognosis in pulmonary arterial hypertension in patients surviving ≤2 years and those surviving ≥5 years after baseline right-sided cardiac catheterization.
    Batal O; Khatib OF; Dweik RA; Hammel JP; McCarthy K; Minai OA
    Am J Cardiol; 2012 May; 109(10):1514-20. PubMed ID: 22360818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
    Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
    Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of right-to-left shunting and poor exercise gas exchange for predicting prognosis in patients with pulmonary arterial hypertension.
    Oudiz RJ; Midde R; Hovenesyan A; Sun XG; Roveran G; Hansen JE; Wasserman K
    Am J Cardiol; 2010 Apr; 105(8):1186-91. PubMed ID: 20381675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
    Kylhammar D; Kjellström B; Hjalmarsson C; Jansson K; Nisell M; Söderberg S; Wikström G; Rådegran G
    Eur Heart J; 2018 Dec; 39(47):4175-4181. PubMed ID: 28575277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
    Gupta R; Baughman RP; Nathan SD; Wells AU; Kouranos V; Alhamad EH; Culver DA; Barney J; Carmona EM; Cordova FC; Huitema M; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Price LC; Wort SJ; Shlobin OA
    Respir Med; 2022 May; 196():106801. PubMed ID: 35316723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Exercise Tolerance With Hemodynamic Parameters for Pulmonary Arterial Hypertension and for Chronic Thromboembolic Pulmonary Hypertension.
    Tsuboi Y; Tanaka H; Nishio R; Sawa T; Terashita D; Nakayama K; Satomi-Kobayashi S; Sakai Y; Emoto N; Hirata KI
    J Cardiopulm Rehabil Prev; 2017 Sep; 37(5):341-346. PubMed ID: 28671932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
    Sahay S; Villasmil Hernandez N; Wang F; Wooten M; Nguyen DT; Fauvel C; Benza R; Graviss EA
    Chest; 2024 Aug; 166(2):373-387. PubMed ID: 38447640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: a Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis.
    Benza RL; Miller DP; Foreman AJ; Frost AE; Badesch DB; Benton WW; McGoon MD
    J Heart Lung Transplant; 2015 Mar; 34(3):356-61. PubMed ID: 25447572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension.
    Golpe R; Castro-Añón O; Pérez-de-Llano LA; González-Juanatey C; Muñiz-Fernández C; Testa-Fernández A; Pérez-Fernández R
    Heart Lung; 2014; 43(1):72-6. PubMed ID: 24041565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
    Frost AE; Badesch DB; Miller DP; Benza RL; Meltzer LA; McGoon MD
    Chest; 2013 Nov; 144(5):1521-1529. PubMed ID: 23907471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiography, 6-minute walk distance, and distance-saturation product as predictors of pulmonary arterial hypertension in idiopathic pulmonary fibrosis.
    Modrykamien AM; Gudavalli R; McCarthy K; Parambil J
    Respir Care; 2010 May; 55(5):584-8. PubMed ID: 20420729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeatability and responsiveness of exercise tests in pulmonary arterial hypertension.
    Mainguy V; Malenfant S; Neyron AS; Bonnet S; Maltais F; Saey D; Provencher S
    Eur Respir J; 2013 Aug; 42(2):425-34. PubMed ID: 23100508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
    Garin MC; Highland KB; Silver RM; Strange C
    J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiological response to the six-minute walk test in pulmonary arterial hypertension.
    Deboeck G; Niset G; Vachiery JL; Moraine JJ; Naeije R
    Eur Respir J; 2005 Oct; 26(4):667-72. PubMed ID: 16204599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Pulmonary Artery Compliance in Patients with Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease.
    Cheng XL; Liu ZH; Gu Q; Ni XH; Luo Q; Zhao ZH; He JG; Xiong CM
    Int Heart J; 2017 Oct; 58(5):731-738. PubMed ID: 28966315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.